Complete Renin-Angiotensin-Aldosterone System (RAAS) Blockade in High-Risk Patients: Recent Insights From Renin Blockade Studies

被引：9
作者：
Rajagopalan, Sanjay [1 ]
Bakris, George L. [2 ]
Abraham, William T. [1 ]
Pitt, Bertram [3 ]
Brook, Robert D. [3 ]
机构：
[1] Ohio State Univ, Div Cardiovasc Med, Wexner Med Ctr, Columbus, OH 43210 USA
[2] Univ Chicago, Pritzker Sch Med, Hypertens Dis Unit, Chicago, IL 60637 USA
[3] Univ Michigan, Div Cardiovasc Med, Ann Arbor, MI 48109 USA
来源：
HYPERTENSION | 2013年 / 62卷 / 03期
关键词：
LEFT-VENTRICULAR MASS; BLOOD-PRESSURE; INHIBITOR ALISKIREN; HEART-FAILURE; RECEPTOR; EXPRESSION; LOSARTAN; ACE2; COMBINATION; EFFICACY;
D O I：
10.1161/HYPERTENSIONAHA.113.01504
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
[No abstract available]
引用
收藏
页码：444 / 449
页数：6
相关论文
共 46 条
[1]   Renin inhibition with aliskiren: where are we now, and where are we going? [J].
Azizi, M ;
Webb, R ;
Nussberger, J ;
Hollenberg, NK .
JOURNAL OF HYPERTENSION, 2006, 24 (02) :243-256
[2]   Randomized Study of Antihypertensive Efficacy and Safety of Combination Aliskiren/Valsartan vs Valsartan Monotherapy in Hypertensive Participants With Type 2 Diabetes Mellitus [J].
Bakris, George L. ;
Oparil, Suzanne ;
Purkayastha, Das ;
Yadao, Anthony M. ;
Alessi, Thomas ;
Sowers, James R. .
JOURNAL OF CLINICAL HYPERTENSION, 2013, 15 (02) :92-100
[3]   Blood Pressure Targets in Subjects With Type 2 Diabetes Mellitus/Impaired Fasting Glucose Observations From Traditional and Bayesian Random-Effects Meta-Analyses of Randomized Trials [J].
Bangalore, Sripal ;
Kumar, Sunil ;
Lobach, Iryna ;
Messerli, Franz H. .
CIRCULATION, 2011, 123 (24) :2799-+
[4]   (Pro)renin and its receptors: pathophysiological implications [J].
Batenburg, Wendy W. ;
Danser, A. H. Jan .
CLINICAL SCIENCE, 2012, 123 (3-4) :121-133
[5]   Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial [J].
Brown, Morris J. ;
McInnes, Gordon T. ;
Papst, Cheraz Cherif ;
Zhang, Jack ;
MacDonald, Thomas M. .
LANCET, 2011, 377 (9762) :312-320
[6]   The renin rise with aliskiren: It's simply stoichiometry [J].
Danser, A. H. Jan ;
Charney, Alan ;
Feldman, David L. ;
Nussberger, Juerg ;
Fisher, Naomi ;
Hollenberg, Norman .
HYPERTENSION, 2008, 51 (04) :E27-E28
[7]   Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes [J].
Dong, Y. F. ;
Liu, L. ;
Kataoka, K. ;
Nakamura, T. ;
Fukuda, M. ;
Tokutomi, Y. ;
Nako, H. ;
Ogawa, H. ;
Kim-Mitsuyama, S. .
DIABETOLOGIA, 2010, 53 (01) :180-191
[8]   A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 [J].
Donoghue, M ;
Hsieh, F ;
Baronas, E ;
Godbout, K ;
Gosselin, M ;
Stagliano, N ;
Donovan, M ;
Woolf, B ;
Robison, K ;
Jeyaseelan, R ;
Breitbart, RE ;
Acton, S .
CIRCULATION RESEARCH, 2000, 87 (05) :E1-E9
[9]   Effects of Aliskiren on Blood Pressure, Albuminuria, and (Pro)Renin Receptor Expression in Diabetic TG(mRen-2)27 Rats [J].
Feldman, David L. ;
Jin, Liang ;
Xuan, Hong ;
Contrepas, Aurelie ;
Zhou, Yinong ;
Webb, Randy L. ;
Mueller, Dominik N. ;
Feldt, Sandra ;
Cumin, Frederick ;
Maniara, Wieslawa ;
Persohn, Elke ;
Schuetz, Helmut ;
Danser, A. H. Jan ;
Nguyen, Genevieve .
HYPERTENSION, 2008, 52 (01) :130-136
[10]   New insights into the renoprotective actions of the renin inhibitor aliskiren in experimental renal disease [J].
Feldman, David L. .
HYPERTENSION RESEARCH, 2010, 33 (04) :279-287
12345